CHAPEL HILL, N.C., May 16 /PRNewswire/ -- Superior launch strategies allow best-in-class pharmaceutical companies to emerge as a leader in crowded markets. To secure "share of voice" for a new product, leading companies develop specific uptake strategies to support business needs and ensure a successful launch. How leading pharmaceutical companies achieve attention in the market during a global launch often defines a product's success.
"Best Practices for Winning Product Launch Successes" is an industry-wide benchmark study on global product launches. The study identifies the winning strategies, practices and investment patterns that define successful global marketing launches. The study findings will enable executives and managers to move knowledgeably forward toward the objective of developing their own world- class marketing launch capabilities.
The study comprehensively covers functions such as: Strategy and Structure, Managing Cross-Functional Teams, Thought Leader Development, Sales Force Support, Market Research, Marketing Activities, Life Cycle Management.
The leading best practices, managerial insights, benchmark metrics and key findings in the study are drawn from interviews with more than 25 key executives directly involved in 12 blockbuster product launches and pharmaceutical product launch information was gathered form many valuable sources, including Best Practices LLC's own proprietary database.
Download a summary of "Best Practices in Global Pharmaceutical Launches" at http://www3.best-in-class.com/rr944.htm. For more information, contact Cameron Tew at 919-767-9246 or at email@example.com .
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. For more information, call 919-403-0251 or visit http://www.best-in-class.com .
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved